Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

crop care australasia pty ltd - formothion | xylene - insecticide - apricot | field crop | fig | fruit crop or tree | grapefruit | lemon | meyer lemon | orange | ornamental | pasture | pome fruit - aphid | azalea lace bug | general weed - see label | lucerne flea | mediterranean fruit fly | redlegged earth mite | thrip | tomato russet mite | woolly aphid | barnyard grass | blady grass | brome grass | buffalo grass | clover springtail | couch grass | dandelion | flatweed | guinea grass | kikuyu grass | lantana | nutgrass | onion weed | oxalis | paspalum | red legged earth mite | rhodes grass | ryegrass | sorrel | st john's wort | thrips spp. | tomato mite (47236) | weed control - general | winter grass

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

agri west pty limited - omethoate - liquid concentrate - omethoate organophosphorus active 290.0 g/l - miticide - barrier spraying | cereal crop | faba bean | legume | legume crop | lucerne | oilseed crop | pasture | poppy | poppy oilseed | v - blue oat or pea mite | bluegreen aphid | bryobia mite | cowpea aphid | lucerne flea | redlegged earth mite | spotted clover aphid | clover springtail | red legged earth mite

Ireland - English - HPRA (Health Products Regulatory Authority)

laboratorios liconsa, s.a. - formoterol fumarate - inhalation powder, hard capsule - 12 microgram(s) - selective beta-2-adrenoreceptor agonists; formoterol

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

medispec (m) sdn.bhd - formoterol fumarate dihydrate -

European Union - English - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - drugs for obstructive airway diseases, - budesonide/formoterol teva is indicated in adults 18 years of age and older only.asthmabudesonide/formoterol teva is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists.orin patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists.copdsymptomatic treatment of patients with severe copd (fev1 < 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.

European Union - English - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol - asthma - drugs for obstructive airway diseases, - budesonide/formoterol teva pharma b.v. is indicated in adults 18 years of age and older only.asthmabudesonide/formoterol teva pharma b.v. is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate: orin patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists.in patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists. 

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

orion pharma (uk - formoterol fumarate dihydrate - inhalation powder - 12microgram/1dose

European Union - English - EMA (European Medicines Agency)

teva pharma b.v.  - budesonide, formoterol fumarate dihydrate - asthma; pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - budesonide/formoterol teva pharma b.v. is indicated in adults 18 years of age and older only.asthmabudesonide/formoterol teva pharma b.v. is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate:-in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists.or-in patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists.copdsymptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev1) 

Canada - English - Health Canada

astrazeneca canada inc - formoterol fumarate dihydrate; glycopyrronium (glycopyrronium bromide) - aerosol, metered dose - 5.8mcg; 8.3mcg - formoterol fumarate dihydrate 5.8mcg; glycopyrronium (glycopyrronium bromide) 8.3mcg - antimuscarinics antispasmodics

Ireland - English - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - formoterol fumatrate dihydrate - powder for inhalation - 6 microgram(s) - selective beta-2-adrenoreceptor agonists; formoterol